143 related articles for article (PubMed ID: 37595134)
1. Cutaneous leiomyosarcoma: a retrospective review of 45 cases.
Khan S; Asher R; Perkins W; Matin RN
Clin Exp Dermatol; 2023 Dec; 49(1):2-8. PubMed ID: 37595134
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous leiomyosarcoma: dermal and subcutaneous.
Wong GN; Webb A; Gyorki D; McCormack C; Tran P; Ngan SY; Slavin J; Henderson MA
Australas J Dermatol; 2020 Aug; 61(3):243-249. PubMed ID: 32537765
[TBL] [Abstract][Full Text] [Related]
3. Leiomyosarcoma of the skin: clinical, histopathologic, and prognostic factors that influence outcomes.
Winchester DS; Hocker TL; Brewer JD; Baum CL; Hochwalt PC; Arpey CJ; Otley CC; Roenigk RK
J Am Acad Dermatol; 2014 Nov; 71(5):919-25. PubMed ID: 25174541
[TBL] [Abstract][Full Text] [Related]
4. Treatment outcome of superficial leiomyosarcoma.
Wellings EP; Tibbo ME; Rose PS; Folpe AL; Houdek MT
J Surg Oncol; 2021 Jan; 123(1):127-132. PubMed ID: 33063336
[TBL] [Abstract][Full Text] [Related]
5. Leiomyosarcoma of the skin: review of the literature with an emphasis on prognosis and management.
Kazlouskaya V; Lai YC; Khachemoune A
Int J Dermatol; 2020 Feb; 59(2):165-172. PubMed ID: 31729020
[TBL] [Abstract][Full Text] [Related]
6. S1-guideline cutaneous and subcutaneous leiomyosarcoma.
Helbig D; Dippel E; Erdmann M; Frisman A; Kage P; Leiter U; Mentzel T; Seidel C; Weishaupt C; Ziemer M; Ugurel S
J Dtsch Dermatol Ges; 2023 May; 21(5):555-563. PubMed ID: 36999582
[TBL] [Abstract][Full Text] [Related]
7. Primary cutaneous and subcutaneous leiomyosarcomas: evolution and prognostic factors.
Aneiros-Fernandez J; Antonio Retamero J; Husein-Elahmed H; Ovalle F; Aneiros-Cachaza J
Eur J Dermatol; 2016; 26(1):9-12. PubMed ID: 26678649
[TBL] [Abstract][Full Text] [Related]
8. A retrospective study of 694 Basal Cell Carcinoma excisions to quantify deep margin documentation and clearance compared to histological type and surgical margin.
Kiely JR; Patel AJK
J Plast Reconstr Aesthet Surg; 2019 Nov; 72(11):1805-1812. PubMed ID: 31331722
[TBL] [Abstract][Full Text] [Related]
9. Primary cutaneous leiomyosarcoma. A histological and immunohistochemical study of 9 cases, with ultrastructural correlation.
Swanson PE; Stanley MW; Scheithauer BW; Wick MR
J Cutan Pathol; 1988 Jun; 15(3):129-41. PubMed ID: 3294254
[TBL] [Abstract][Full Text] [Related]
10. Primary cutaneous leiomyosarcoma: clinicopathological analysis of 36 cases.
Massi D; Franchi A; Alos L; Cook M; Di Palma S; Enguita AB; Ferrara G; Kazakov DV; Mentzel T; Michal M; Panelos J; Rodriguez-Peralto JL; Santucci M; Tragni G; Zioga A; Dei Tos AP
Histopathology; 2010 Jan; 56(2):251-62. PubMed ID: 20102404
[TBL] [Abstract][Full Text] [Related]
11. [Varying characteristics of subcutaneous and dermal leiomyosarcomas. Two case reports and literature review].
Seemann N; Lehmann P
Hautarzt; 2006 May; 57(5):428-33. PubMed ID: 15856144
[TBL] [Abstract][Full Text] [Related]
12. Optimal surgical treatment for paratesticular leiomyosarcoma: retrospective analysis of 217 reported cases.
Kamitani R; Matsumoto K; Takeda T; Mizuno R; Oya M
BMC Cancer; 2022 Jan; 22(1):15. PubMed ID: 34980039
[TBL] [Abstract][Full Text] [Related]
13. Basal cell carcinoma histological clearance margins: an analysis of 1539 conventionally excised tumours. Wider still and deeper?
Griffiths RW; Suvarna SK; Stone J
J Plast Reconstr Aesthet Surg; 2007; 60(1):41-7. PubMed ID: 17126265
[TBL] [Abstract][Full Text] [Related]
14. Guidelines for the excision of cutaneous squamous cell cancers in the United Kingdom: the best cut is the deepest.
Khan AA; Potter M; Cubitt JJ; Khoda BJ; Smith J; Wright EH; Scerri G; Crick A; Cassell OC; Budny PG
J Plast Reconstr Aesthet Surg; 2013 Apr; 66(4):467-71. PubMed ID: 23352886
[TBL] [Abstract][Full Text] [Related]
15. Superficial leiomyosarcoma treated with Mohs micrographic surgery.
Humphreys TR; Finkelstein DH; Lee JB
Dermatol Surg; 2004 Jan; 30(1):108-12. PubMed ID: 14692939
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous leiomyosarcoma - Case report.
Ciurea ME; Georgescu CV; Radu CC; Georgescu CC; Stoica LE
J Med Life; 2014 Jun; 7(2):270-3. PubMed ID: 25408738
[TBL] [Abstract][Full Text] [Related]
17. From Morphea to Dermatofibrosarcoma Protuberans.
Crnarić I; Šitum M; Delaš Aždajić M; Vučić M; Buljan M
Acta Dermatovenerol Croat; 2022 Sep; 30(2):113-115. PubMed ID: 36254545
[TBL] [Abstract][Full Text] [Related]
18. Atypical intradermal smooth muscle neoplasms: clinicopathologic analysis of 84 cases and a reappraisal of cutaneous "leiomyosarcoma".
Kraft S; Fletcher CD
Am J Surg Pathol; 2011 Apr; 35(4):599-607. PubMed ID: 21358302
[TBL] [Abstract][Full Text] [Related]
19. Subcutaneous Leiomyosarcoma: An Aggressive Malignancy Portending a Significant Risk of Metastasis and Death.
Bresler SC; Gosnell HL; Ko JS; Angeles CV; Ronen S; Billings SD; Patel RM
Am J Surg Pathol; 2023 Dec; 47(12):1417-1424. PubMed ID: 37727934
[TBL] [Abstract][Full Text] [Related]
20. Recurrent cutaneous leiomyosarcoma.
Wascher RA; Lee MY
Cancer; 1992 Jul; 70(2):490-2. PubMed ID: 1617597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
